Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

• প্রধান লেখক: Franco M. Piazza (লেখক), Miia Virta (লেখক), Marita Paassilta (লেখক), Benita Ukkonen (লেখক), Anitta Ahonen (লেখক), Alejandra Esteves-Jaramillo (লেখক), Aino Forsten (লেখক), Ilkka Seppa (লেখক), Jian Ding (লেখক), David Neveu (লেখক), Emilia Jordanov (লেখক), Mandeep S. Dhingra (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier with MenACYW-TT or MCV4-TT (Nimenrix®). In this Phas...